Pediatric healthcare market – Global Industrial Analysis and Forecast 2027 – by Drug class, by Disease, by Service type, and by Regions.

Pediatric healthcare market – Global Industrial Analysis and Forecast 2027 – by Drug class, by Disease, by Service type, and by Regions.

Market Scenario

Global Pediatric Healthcare Market was valued at USD xx million in 2018 and is expected to reach at USD xx million by 2026 at a CAGR of xx% over forecast period 2019 -2026. Global Pediatric Healthcare Market Pediatrics is a branch of medicine which deals with the health, growth, and development of infants, children, and adolescents. Unhealthy lifestyle habits and rise in obese pediatric population propel the pediatric health care products and services market. The world is going through a rapid nutritional and epidemiological shift, rise in prevalence of obesity, cardiovascular disease, nutrition-related chronic diseases, and cancer. Changes in lifestyle, for instance, in eating habits, have led to an increase in obesity.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Increase in demand for chronic disease treatment, Diarrhea and injury related disease is more common in children; however, these diseases vary from short term to long-term treatments that consume a lot time and exert financial pressures on the parents. Changes in child care trend increases the prevalence rate of pediatric diseases. These factors are propelling the growth of Pediatric healthcare market over forecast period. By Drug Class market is segmented into Antibiotics, Analgesics, Anti-asthmatics, Anti-depressants, Antidiarrheal, Antifungal, Anti-histamines, Antihypertensives, and Anti-metabolites. By Services Type market is segmented into Child Psychiatry Services, Gastrointestinal Services, Pediatric Cancer Services, Pediatric Diabetes Services, Pediatric Heart Service and Others. By geography, Global Pediatric Healthcare Market is segmented into APAC, North America, Europe, MEA& Africa and Latin America. North America dominated the global pediatric healthcare market with an xx% revenue share in 2018, thanks to the launch of new drugs by pharmaceutical companies for pediatric patients. Increasing adoption of modern medical technology, and the regional presence of the key market players. North America will maintain its dominance over the forecast period as well. Europe held the second position in the global pediatric healthcare market in 2018, due to the increasing demand for chronic disease treatment, rising healthcare infrastructure, and growing enterprises of medical hospitals and clinics. Germany, the UK, and France are major countries in the European Pediatric Healthcare Market. The objective of the report is to present comprehensive analysis of Pediatric Healthcare Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Pediatric Healthcare Market dynamics, structure by analysing the market segments, and project the global critical communication market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Pediatric Healthcare Market make the report investor’s guide.

Pediatric Healthcare Market Segmentation by Drug Class market

• Antibiotics • Analgesics • Anti-asthmatics • Anti-depressants • Antidiarrheal • Antifungal • Anti-histamines • Antihypertensives • Anti-metabolites

Pediatric Healthcare Market Segmentation by Disease Disorder

• Allergy and Respiratory • Cancer • Cardiovascular • Central Nervous System • Gastrointestinal • Hormonal Imbalance • Infections • Others

Pediatric Healthcare Market Segmentation by Services Type

• Child Psychiatry Services • Gastrointestinal Services • Pediatric Cancer Services • Pediatric Diabetes Services • Pediatric Heart Services • Others

Pediatric Healthcare Market Segmentation by Region

• APAC • North America • Europe • Latin America • MEA& Africa

Pediatric Healthcare Market Major Key Players:

• AstraZeneca plc • Pfizer Inc. • Sanofi S.A. • Boehringer Ingelheim GmbH • Eisai Co., Ltd. • Gilead Sciences, Inc. • GlaxoSmithKline plc. • Merck and Co. Inc. • Mylan N.V. • Novartis AG, • Pediapharm, Inc. • Gilead Sciences, • GlaxosmithklinePlc • Johnson & Johnson • Eli Lilly • AxcanPharmaUSA

Table of Contents

Pediatric Healthcare Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.2. Secondary data 2.3.3. Secondary Sources 2.3.4. Primary Research 2.3.5. Data from Primary Sources 2.3.6. Breakdown of Primary Sources 3. Executive Summary: Global Pediatric Healthcare Market, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Pediatric Healthcare Market Analysis and Forecast 6.1. Global Pediatric Healthcare Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Pediatric Healthcare Market Analysis and Forecast, By Drug Class 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Pediatric Healthcare Market Value Share Analysis, By Drug Class 7.4. Global Pediatric Healthcare Market Size (US$ Bn) Forecast, By Drug Class 7.5. Global Pediatric Healthcare Market Analysis, By Drug Class 7.6. Global Pediatric Healthcare Market Attractiveness Analysis, By Drug Class 8. Global Pediatric Healthcare Market Analysis and Forecast, By Disease Disorder 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Pediatric Healthcare Market Value Share Analysis, By Disease Disorder 8.4. Global Pediatric Healthcare Market Size (US$ Bn) Forecast, By Disease Disorder 8.5. Global Pediatric Healthcare Market Analysis, By Disease Disorder 8.6. Global Pediatric Healthcare Market Attractiveness Analysis, By Disease Disorder 9. Global Pediatric Healthcare Market Analysis and Forecast, by Services Type 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Pediatric Healthcare Market Value Share Analysis, by Services Type 9.4. Global Pediatric Healthcare Market Size (US$ Bn) Forecast, by Services Type 9.5. Global Pediatric Healthcare Market Analysis, by Services Type 9.6. Global Pediatric Healthcare Market Attractiveness Analysis, by Services Type 10. Global Pediatric Healthcare Market Analysis, by Region 10.1. Global Pediatric Healthcare Market Value Share Analysis, by Region 10.2. Global Pediatric Healthcare Market Size (US$ Bn) Forecast, by Region 10.3. Global Pediatric Healthcare Market Attractiveness Analysis, by Region 11. North America Pediatric Healthcare Market Analysis 11.1. Key Findings 11.2. North America Pediatric Healthcare Market Overview 11.3. North America Pediatric Healthcare Market Value Share Analysis, By Drug Class 11.4. North America Pediatric Healthcare Market Forecast, By Drug Class 11.4.1. Antibiotics 11.4.2. Analgesics 11.4.3. Anti-asthmatics 11.4.4. Anti-depressants 11.4.5. Antidiarrheal 11.4.6. Antifungal 11.4.7. Anti-histamines 11.4.8. Antihypertensives 11.4.9. Anti-metabolites 11.5. North America Pediatric Healthcare Market Value Share Analysis, By Disease Disorder 11.6. North America Pediatric Healthcare Market Forecast, By Disease Disorder 11.6.1. Software 11.6.2. Hardware 11.6.3. Services 11.7. North America Pediatric Healthcare Market Value Share Analysis, by Services Type 11.8. North America Pediatric Healthcare Market Forecast, by Services Type 11.8.1. Child Psychiatry Services 11.8.2. Gastrointestinal Services 11.8.3. Pediatric Cancer Services 11.8.4. Pediatric Diabetes Services 11.8.5. Pediatric Heart Services 11.8.6. Others 11.9. North America Pediatric Healthcare Market Value Share Analysis, by Country 11.10. North America Pediatric Healthcare Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Pediatric Healthcare Market Analysis, by Country 11.12. U.S. Pediatric Healthcare Market Forecast, By Drug Class 11.12.1. Antibiotics 11.12.2. Analgesics 11.12.3. Anti-asthmatics 11.12.4. Anti-depressants 11.12.5. Antidiarrheal 11.12.6. Antifungal 11.12.7. Anti-histamines 11.12.8. Antihypertensives 11.12.9. Anti-metabolites 11.13. U.S. Pediatric Healthcare Market Forecast, By Disease Disorder 11.13.1. Allergy and Respiratory 11.13.2. Cancer 11.13.3. Cardiovascular 11.13.4. Central Nervous System 11.13.5. Gastrointestinal 11.13.6. Hormonal Imbalance 11.13.7. Infections 11.13.8. Others 11.14. U.S. Pediatric Healthcare Market Forecast, by Services Type 11.14.1. Child Psychiatry Services 11.14.2. Gastrointestinal Services 11.14.3. Pediatric Cancer Services 11.14.4. Pediatric Diabetes Services 11.14.5. Pediatric Heart Services 11.14.6. Others 11.15. Canada Pediatric Healthcare Market Forecast, By Drug Class 11.15.1. Antibiotics 11.15.2. Analgesics 11.15.3. Anti-asthmatics 11.15.4. Anti-depressants 11.15.5. Antidiarrheal 11.15.6. Antifungal 11.15.7. Anti-histamines 11.15.8. Antihypertensives 11.15.9. Anti-metabolites 11.16. Canada Pediatric Healthcare Market Forecast, By Disease Disorder 11.16.1. Allergy and Respiratory 11.16.2. Cancer 11.16.3. Cardiovascular 11.16.4. Central Nervous System 11.16.5. Gastrointestinal 11.16.6. Hormonal Imbalance 11.16.7. Infections 11.16.8. Others 11.17. Canada Pediatric Healthcare Market Forecast, by Services Type 11.17.1. Child Psychiatry Services 11.17.2. Gastrointestinal Services 11.17.3. Pediatric Cancer Services 11.17.4. Pediatric Diabetes Services 11.17.5. Pediatric Heart Services 11.17.6. Others 11.18. North America Pediatric Healthcare Market Attractiveness Analysis 11.18.1. By Drug Class 11.18.2. By Disease Disorder 11.18.3. By Services Type 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Development 12. Europe Pediatric Healthcare Market Analysis 12.1. Key Findings 12.2. Europe Pediatric Healthcare Market Overview 12.3. Europe Pediatric Healthcare Market Value Share Analysis, By Drug Class 12.4. Europe Pediatric Healthcare Market Forecast, By Drug Class 12.4.1. Antibiotics 12.4.2. Analgesics 12.4.3. Anti-asthmatics 12.4.4. Anti-depressants 12.4.5. Antidiarrheal 12.4.6. Antifungal 12.4.7. Anti-histamines 12.4.8. Antihypertensives 12.4.9. Anti-metabolites 12.5. Europe Pediatric Healthcare Market Value Share Analysis, By Disease Disorder 12.6. Europe Pediatric Healthcare Market Forecast, By Disease Disorder 12.6.1. Allergy and Respiratory 12.6.2. Cancer 12.6.3. Cardiovascular 12.6.4. Central Nervous System 12.6.5. Gastrointestinal 12.6.6. Hormonal Imbalance 12.6.7. Infections 12.6.8. Others 12.7. Europe Pediatric Healthcare Market Value Share Analysis, by Services Type 12.8. Europe Pediatric Healthcare Market Forecast, by Services Type 12.8.1. Child Psychiatry Services 12.8.2. Gastrointestinal Services 12.8.3. Pediatric Cancer Services 12.8.4. Pediatric Diabetes Services 12.8.5. Pediatric Heart Services 12.8.6. Others 12.9. Europe Pediatric Healthcare Market Value Share Analysis, by Country 12.10. Europe Pediatric Healthcare Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Pediatric Healthcare Market Analysis, by Country 12.12. Germany Pediatric Healthcare Market Forecast, By Drug Class 12.12.1. Antibiotics 12.12.2. Analgesics 12.12.3. Anti-asthmatics 12.12.4. Anti-depressants 12.12.5. Antidiarrheal 12.12.6. Antifungal 12.12.7. Anti-histamines 12.12.8. Antihypertensives 12.12.9. Anti-metabolites 12.13. Germany Pediatric Healthcare Market Forecast, By Disease Disorder 12.13.1. Allergy and Respiratory 12.13.2. Cancer 12.13.3. Cardiovascular 12.13.4. Central Nervous System 12.13.5. Gastrointestinal 12.13.6. Hormonal Imbalance 12.13.7. Infections 12.13.8. Others 12.14. Germany Pediatric Healthcare Market Forecast, by Services Type 12.14.1. Child Psychiatry Services 12.14.2. Gastrointestinal Services 12.14.3. Pediatric Cancer Services 12.14.4. Pediatric Diabetes Services 12.14.5. Pediatric Heart Services 12.14.6. Others 12.15. U.K. Pediatric Healthcare Market Forecast, By Drug Class 12.15.1. Antibiotics 12.15.2. Analgesics 12.15.3. Anti-asthmatics 12.15.4. Anti-depressants 12.15.5. Antidiarrheal 12.15.6. Antifungal 12.15.7. Anti-histamines 12.15.8. Antihypertensives 12.15.9. Anti-metabolites 12.16. U.K. Pediatric Healthcare Market Forecast, By Disease Disorder 12.16.1. Allergy and Respiratory 12.16.2. Cancer 12.16.3. Cardiovascular 12.16.4. Central Nervous System 12.16.5. Gastrointestinal 12.16.6. Hormonal Imbalance 12.16.7. Infections 12.16.8. Others 12.17. U.K. Pediatric Healthcare Market Forecast, by Services Type 12.17.1. Child Psychiatry Services 12.17.2. Gastrointestinal Services 12.17.3. Pediatric Cancer Services 12.17.4. Pediatric Diabetes Services 12.17.5. Pediatric Heart Services 12.17.6. Others 12.18. France Pediatric Healthcare Market Forecast, By Drug Class 12.18.1. Antibiotics 12.18.2. Analgesics 12.18.3. Anti-asthmatics 12.18.4. Anti-depressants 12.18.5. Antidiarrheal 12.18.6. Antifungal 12.18.7. Anti-histamines 12.18.8. Antihypertensives 12.18.9. Anti-metabolites 12.19. France Pediatric Healthcare Market Forecast, By Disease Disorder 12.19.1. Allergy and Respiratory 12.19.2. Cancer 12.19.3. Cardiovascular 12.19.4. Central Nervous System 12.19.5. Gastrointestinal 12.19.6. Hormonal Imbalance 12.19.7. Infections 12.19.8. Others 12.20. France Pediatric Healthcare Market Forecast, by Services Type 12.20.1. Child Psychiatry Services 12.20.2. Gastrointestinal Services 12.20.3. Pediatric Cancer Services 12.20.4. Pediatric Diabetes Services 12.20.5. Pediatric Heart Services 12.20.6. Others 12.21. Italy Pediatric Healthcare Market Forecast, By Drug Class 12.21.1. Antibiotics 12.21.2. Analgesics 12.21.3. Anti-asthmatics 12.21.4. Anti-depressants 12.21.5. Antidiarrheal 12.21.6. Antifungal 12.21.7. Anti-histamines 12.21.8. Antihypertensives 12.21.9. Anti-metabolites 12.22. Italy Pediatric Healthcare Market Forecast, By Disease Disorder 12.22.1. Allergy and Respiratory 12.22.2. Cancer 12.22.3. Cardiovascular 12.22.4. Central Nervous System 12.22.5. Gastrointestinal 12.22.6. Hormonal Imbalance 12.22.7. Infections 12.22.8. Others 12.23. Italy Pediatric Healthcare Market Forecast, by Services Type 12.23.1. Child Psychiatry Services 12.23.2. Gastrointestinal Services 12.23.3. Pediatric Cancer Services 12.23.4. Pediatric Diabetes Services 12.23.5. Pediatric Heart Services 12.23.6. Others 12.24. Spain Pediatric Healthcare Market Forecast, By Drug Class 12.24.1. Antibiotics 12.24.2. Analgesics 12.24.3. Anti-asthmatics 12.24.4. Anti-depressants 12.24.5. Antidiarrheal 12.24.6. Antifungal 12.24.7. Anti-histamines 12.24.8. Antihypertensives 12.24.9. Anti-metabolites 12.25. Spain Pediatric Healthcare Market Forecast, By Disease Disorder 12.25.1. Allergy and Respiratory 12.25.2. Cancer 12.25.3. Cardiovascular 12.25.4. Central Nervous System 12.25.5. Gastrointestinal 12.25.6. Hormonal Imbalance 12.25.7. Infections 12.25.8. Others 12.26. Spain Pediatric Healthcare Market Forecast, by Services Type 12.26.1. Child Psychiatry Services 12.26.2. Gastrointestinal Services 12.26.3. Pediatric Cancer Services 12.26.4. Pediatric Diabetes Services 12.26.5. Pediatric Heart Services 12.26.6. Others 12.27. Rest of Europe Pediatric Healthcare Market Forecast, By Drug Class 12.27.1. Antibiotics 12.27.2. Analgesics 12.27.3. Anti-asthmatics 12.27.4. Anti-depressants 12.27.5. Antidiarrheal 12.27.6. Antifungal 12.27.7. Anti-histamines 12.27.8. Antihypertensives 12.27.9. Anti-metabolites 12.28. Rest of Europe Pediatric Healthcare Market Forecast, By Disease Disorder 12.28.1. Allergy and Respiratory 12.28.2. Cancer 12.28.3. Cardiovascular 12.28.4. Central Nervous System 12.28.5. Gastrointestinal 12.28.6. Hormonal Imbalance 12.28.7. Infections 12.28.8. Others 12.29. Rest of Europe Pediatric Healthcare Market Forecast, by Services Type 12.29.1. Child Psychiatry Services 12.29.2. Gastrointestinal Services 12.29.3. Pediatric Cancer Services 12.29.4. Pediatric Diabetes Services 12.29.5. Pediatric Heart Services 12.29.6. Others 12.30. Europe Pediatric Healthcare Market Attractiveness Analysis 12.30.1. By Drug Class 12.30.2. By Disease Disorder 12.30.3. By Services Type 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Development 13. Asia Pacific Pediatric Healthcare Market Analysis 13.1. Key Findings 13.2. Asia Pacific Pediatric Healthcare Market Overview 13.3. Asia Pacific Pediatric Healthcare Market Value Share Analysis, By Drug Class 13.4. Asia Pacific Pediatric Healthcare Market Forecast, By Drug Class 13.4.1. Antibiotics 13.4.2. Analgesics 13.4.3. Anti-asthmatics 13.4.4. Anti-depressants 13.4.5. Antidiarrheal 13.4.6. Antifungal 13.4.7. Anti-histamines 13.4.8. Antihypertensives 13.4.9. Anti-metabolites 13.5. Asia Pacific Pediatric Healthcare Market Value Share Analysis, By Disease Disorder 13.6. Asia Pacific Pediatric Healthcare Market Forecast, By Disease Disorder 13.6.1. Allergy and Respiratory 13.6.2. Cancer 13.6.3. Cardiovascular 13.6.4. Central Nervous System 13.6.5. Gastrointestinal 13.6.6. Hormonal Imbalance 13.6.7. Infections 13.6.8. Others 13.7. Asia Pacific Pediatric Healthcare Market Value Share Analysis, by Services Type 13.8. Asia Pacific Pediatric Healthcare Market Forecast, by Services Type 13.8.1. Child Psychiatry Services 13.8.2. Gastrointestinal Services 13.8.3. Pediatric Cancer Services 13.8.4. Pediatric Diabetes Services 13.8.5. Pediatric Heart Services 13.8.6. Others 13.9. Asia Pacific Pediatric Healthcare Market Value Share Analysis, by Country 13.10. Asia Pacific Pediatric Healthcare Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Pediatric Healthcare Market Analysis, by Country 13.12. China Pediatric Healthcare Market Forecast, By Drug Class 13.12.1. Antibiotics 13.12.2. Analgesics 13.12.3. Anti-asthmatics 13.12.4. Anti-depressants 13.12.5. Antidiarrheal 13.12.6. Antifungal 13.12.7. Anti-histamines 13.12.8. Antihypertensives 13.12.9. Anti-metabolites 13.13. China Pediatric Healthcare Market Forecast, By Disease Disorder 13.13.1. Allergy and Respiratory 13.13.2. Cancer 13.13.3. Cardiovascular 13.13.4. Central Nervous System 13.13.5. Gastrointestinal 13.13.6. Hormonal Imbalance 13.13.7. Infections 13.13.8. Others 13.14. China Pediatric Healthcare Market Forecast, by Services Type 13.14.1. Child Psychiatry Services 13.14.2. Gastrointestinal Services 13.14.3. Pediatric Cancer Services 13.14.4. Pediatric Diabetes Services 13.14.5. Pediatric Heart Services 13.14.6. Others 13.15. India Pediatric Healthcare Market Forecast, By Drug Class 13.15.1. Antibiotics 13.15.2. Analgesics 13.15.3. Anti-asthmatics 13.15.4. Anti-depressants 13.15.5. Antidiarrheal 13.15.6. Antifungal 13.15.7. Anti-histamines 13.15.8. Antihypertensives 13.15.9. Anti-metabolites 13.16. India Pediatric Healthcare Market Forecast, By Disease Disorder 13.16.1. Allergy and Respiratory 13.16.2. Cancer 13.16.3. Cardiovascular 13.16.4. Central Nervous System 13.16.5. Gastrointestinal 13.16.6. Hormonal Imbalance 13.16.7. Infections 13.16.8. Others 13.17. India Pediatric Healthcare Market Forecast, by Services Type 13.17.1. Child Psychiatry Services 13.17.2. Gastrointestinal Services 13.17.3. Pediatric Cancer Services 13.17.4. Pediatric Diabetes Services 13.17.5. Pediatric Heart Services 13.17.6. Others 13.18. Japan Pediatric Healthcare Market Forecast, By Drug Class 13.18.1. Antibiotics 13.18.2. Analgesics 13.18.3. Anti-asthmatics 13.18.4. Anti-depressants 13.18.5. Antidiarrheal 13.18.6. Antifungal 13.18.7. Anti-histamines 13.18.8. Antihypertensives 13.18.9. Anti-metabolites 13.19. Japan Pediatric Healthcare Market Forecast, By Disease Disorder 13.19.1. Allergy and Respiratory 13.19.2. Cancer 13.19.3. Cardiovascular 13.19.4. Central Nervous System 13.19.5. Gastrointestinal 13.19.6. Hormonal Imbalance 13.19.7. Infections 13.19.8. Others 13.20. Japan Pediatric Healthcare Market Forecast, by Services Type 13.20.1. Child Psychiatry Services 13.20.2. Gastrointestinal Services 13.20.3. Pediatric Cancer Services 13.20.4. Pediatric Diabetes Services 13.20.5. Pediatric Heart Services 13.20.6. Others 13.21. ASEAN Pediatric Healthcare Market Forecast, By Drug Class 13.21.1. Antibiotics 13.21.2. Analgesics 13.21.3. Anti-asthmatics 13.21.4. Anti-depressants 13.21.5. Antidiarrheal 13.21.6. Antifungal 13.21.7. Anti-histamines 13.21.8. Antihypertensives 13.21.9. Anti-metabolites 13.22. ASEAN Pediatric Healthcare Market Forecast, By Disease Disorder 13.22.1. Allergy and Respiratory 13.22.2. Cancer 13.22.3. Cardiovascular 13.22.4. Central Nervous System 13.22.5. Gastrointestinal 13.22.6. Hormonal Imbalance 13.22.7. Infections 13.22.8. Others 13.23. ASEAN Pediatric Healthcare Market Forecast, by Services Type 13.23.1. Child Psychiatry Services 13.23.2. Gastrointestinal Services 13.23.3. Pediatric Cancer Services 13.23.4. Pediatric Diabetes Services 13.23.5. Pediatric Heart Services 13.23.6. Others 13.24. Rest of Asia Pacific Pediatric Healthcare Market Forecast, By Drug Class 13.24.1. Antibiotics 13.24.2. Analgesics 13.24.3. Anti-asthmatics 13.24.4. Anti-depressants 13.24.5. Antidiarrheal 13.24.6. Antifungal 13.24.7. Anti-histamines 13.24.8. Antihypertensives 13.24.9. Anti-metabolites 13.25. Rest of Asia Pacific Pediatric Healthcare Market Forecast, By Disease Disorder 13.25.1. Allergy and Respiratory 13.25.2. Cancer 13.25.3. Cardiovascular 13.25.4. Central Nervous System 13.25.5. Gastrointestinal 13.25.6. Hormonal Imbalance 13.25.7. Infections 13.25.8. Others 13.26. Rest of Asia Pacific Pediatric Healthcare Market Forecast, by Services Type 13.26.1. Child Psychiatry Services 13.26.2. Gastrointestinal Services 13.26.3. Pediatric Cancer Services 13.26.4. Pediatric Diabetes Services 13.26.5. Pediatric Heart Services 13.26.6. Others 13.27. Asia Pacific Pediatric Healthcare Market Attractiveness Analysis 13.27.1. By Drug Class 13.27.2. By Disease Disorder 13.27.3. By Services Type 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Development 14. Middle East & Africa Pediatric Healthcare Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Pediatric Healthcare Market Overview 14.3. Middle East & Africa Pediatric Healthcare Market Value Share Analysis, By Drug Class 14.4. Middle East & Africa Pediatric Healthcare Market Forecast, By Drug Class 14.4.1. Antibiotics 14.4.2. Analgesics 14.4.3. Anti-asthmatics 14.4.4. Anti-depressants 14.4.5. Antidiarrheal 14.4.6. Antifungal 14.4.7. Anti-histamines 14.4.8. Antihypertensives 14.4.9. Anti-metabolites 14.5. Middle East & Africa Pediatric Healthcare Market Value Share Analysis, By Disease Disorder 14.6. Middle East & Africa Pediatric Healthcare Market Forecast, By Disease Disorder 14.6.1. Allergy and Respiratory 14.6.2. Cancer 14.6.3. Cardiovascular 14.6.4. Central Nervous System 14.6.5. Gastrointestinal 14.6.6. Hormonal Imbalance 14.6.7. Infections 14.6.8. Others 14.7. Middle East & Africa Pediatric Healthcare Market Value Share Analysis, by Services Type 14.8. Middle East & Africa Pediatric Healthcare Market Forecast, by Services Type 14.8.1. Child Psychiatry Services 14.8.2. Gastrointestinal Services 14.8.3. Pediatric Cancer Services 14.8.4. Pediatric Diabetes Services 14.8.5. Pediatric Heart Services 14.8.6. Others 14.9. Middle East & Africa Pediatric Healthcare Market Value Share Analysis, by Country 14.10. Middle East & Africa Pediatric Healthcare Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Pediatric Healthcare Market Analysis, by Country 14.12. GCC Pediatric Healthcare Market Forecast, By Drug Class 14.12.1. Antibiotics 14.12.2. Analgesics 14.12.3. Anti-asthmatics 14.12.4. Anti-depressants 14.12.5. Antidiarrheal 14.12.6. Antifungal 14.12.7. Anti-histamines 14.12.8. Antihypertensives 14.12.9. Anti-metabolites 14.13. GCC Pediatric Healthcare Market Forecast, By Disease Disorder 14.13.1. Allergy and Respiratory 14.13.2. Cancer 14.13.3. Cardiovascular 14.13.4. Central Nervous System 14.13.5. Gastrointestinal 14.13.6. Hormonal Imbalance 14.13.7. Infections 14.13.8. Others 14.14. GCC Pediatric Healthcare Market Forecast, by Services Type 14.14.1. Child Psychiatry Services 14.14.2. Gastrointestinal Services 14.14.3. Pediatric Cancer Services 14.14.4. Pediatric Diabetes Services 14.14.5. Pediatric Heart Services 14.14.6. Others 14.15. South Africa Pediatric Healthcare Market Forecast, By Drug Class 14.15.1. Antibiotics 14.15.2. Analgesics 14.15.3. Anti-asthmatics 14.15.4. Anti-depressants 14.15.5. Antidiarrheal 14.15.6. Antifungal 14.15.7. Anti-histamines 14.15.8. Antihypertensives 14.15.9. Anti-metabolites 14.16. South Africa Pediatric Healthcare Market Forecast, By Disease Disorder 14.16.1. Allergy and Respiratory 14.16.2. Cancer 14.16.3. Cardiovascular 14.16.4. Central Nervous System 14.16.5. Gastrointestinal 14.16.6. Hormonal Imbalance 14.16.7. Infections 14.16.8. Others 14.17. South Africa Pediatric Healthcare Market Forecast, by Services Type 14.17.1. Child Psychiatry Services 14.17.2. Gastrointestinal Services 14.17.3. Pediatric Cancer Services 14.17.4. Pediatric Diabetes Services 14.17.5. Pediatric Heart Services 14.17.6. Others 14.18. Rest of Middle East & Africa Pediatric Healthcare Market Forecast, By Drug Class 14.18.1. Antibiotics 14.18.2. Analgesics 14.18.3. Anti-asthmatics 14.18.4. Anti-depressants 14.18.5. Antidiarrheal 14.18.6. Antifungal 14.18.7. Anti-histamines 14.18.8. Antihypertensives 14.18.9. Anti-metabolites 14.19. Rest of Middle East & Africa Pediatric Healthcare Market Forecast, By Disease Disorder 14.19.1. Allergy and Respiratory 14.19.2. Cancer 14.19.3. Cardiovascular 14.19.4. Central Nervous System 14.19.5. Gastrointestinal 14.19.6. Hormonal Imbalance 14.19.7. Infections 14.19.8. Others 14.20. Rest of Middle East & Africa Pediatric Healthcare Market Forecast, by Services Type 14.20.1. Child Psychiatry Services 14.20.2. Gastrointestinal Services 14.20.3. Pediatric Cancer Services 14.20.4. Pediatric Diabetes Services 14.20.5. Pediatric Heart Services 14.20.6. Others 14.21. Middle East & Africa Pediatric Healthcare Market Attractiveness Analysis 14.21.1. By Drug Class 14.21.2. By Disease Disorder 14.21.3. By Services Type 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Development 15. South America Pediatric Healthcare Market Analysis 15.1. Key Findings 15.2. South America Pediatric Healthcare Market Overview 15.3. South America Pediatric Healthcare Market Value Share Analysis, By Drug Class 15.4. South America Pediatric Healthcare Market Forecast, By Drug Class 15.4.1. Antibiotics 15.4.2. Analgesics 15.4.3. Anti-asthmatics 15.4.4. Anti-depressants 15.4.5. Antidiarrheal 15.4.6. Antifungal 15.4.7. Anti-histamines 15.4.8. Antihypertensives 15.4.9. Anti-metabolites 15.5. South America Pediatric Healthcare Market Value Share Analysis, By Disease Disorder 15.6. South America Pediatric Healthcare Market Forecast, By Disease Disorder 15.6.1. Allergy and Respiratory 15.6.2. Cancer 15.6.3. Cardiovascular 15.6.4. Central Nervous System 15.6.5. Gastrointestinal 15.6.6. Hormonal Imbalance 15.6.7. Infections 15.6.8. Others 15.7. South America Pediatric Healthcare Market Value Share Analysis, by Services Type 15.8. South America Pediatric Healthcare Market Forecast, by Services Type 15.8.1. Child Psychiatry Services 15.8.2. Gastrointestinal Services 15.8.3. Pediatric Cancer Services 15.8.4. Pediatric Diabetes Services 15.8.5. Pediatric Heart Services 15.8.6. Others 15.9. South America Pediatric Healthcare Market Value Share Analysis, by Country 15.10. South America Pediatric Healthcare Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Pediatric Healthcare Market Analysis, by Country 15.12. Brazil Pediatric Healthcare Market Forecast, By Drug Class 15.12.1. Antibiotics 15.12.2. Analgesics 15.12.3. Anti-asthmatics 15.12.4. Anti-depressants 15.12.5. Antidiarrheal 15.12.6. Antifungal 15.12.7. Anti-histamines 15.12.8. Antihypertensives 15.12.9. Anti-metabolites 15.13. Brazil Pediatric Healthcare Market Forecast, By Disease Disorder 15.13.1. Allergy and Respiratory 15.13.2. Cancer 15.13.3. Cardiovascular 15.13.4. Central Nervous System 15.13.5. Gastrointestinal 15.13.6. Hormonal Imbalance 15.13.7. Infections 15.13.8. Others 15.14. Brazil Pediatric Healthcare Market Forecast, by Services Type 15.14.1. Child Psychiatry Services 15.14.2. Gastrointestinal Services 15.14.3. Pediatric Cancer Services 15.14.4. Pediatric Diabetes Services 15.14.5. Pediatric Heart Services 15.14.6. Others 15.15. Mexico Pediatric Healthcare Market Forecast, By Drug Class 15.15.1. Antibiotics 15.15.2. Analgesics 15.15.3. Anti-asthmatics 15.15.4. Anti-depressants 15.15.5. Antidiarrheal 15.15.6. Antifungal 15.15.7. Anti-histamines 15.15.8. Antihypertensives 15.15.9. Anti-metabolites 15.16. Mexico Pediatric Healthcare Market Forecast, By Disease Disorder 15.16.1. Allergy and Respiratory 15.16.2. Cancer 15.16.3. Cardiovascular 15.16.4. Central Nervous System 15.16.5. Gastrointestinal 15.16.6. Hormonal Imbalance 15.16.7. Infections 15.16.8. Others 15.17. Mexico Pediatric Healthcare Market Forecast, by Services Type 15.17.1. Child Psychiatry Services 15.17.2. Gastrointestinal Services 15.17.3. Pediatric Cancer Services 15.17.4. Pediatric Diabetes Services 15.17.5. Pediatric Heart Services 15.17.6. Others 15.18. Rest of South America Pediatric Healthcare Market Forecast, By Drug Class 15.18.1. Antibiotics 15.18.2. Analgesics 15.18.3. Anti-asthmatics 15.18.4. Anti-depressants 15.18.5. Antidiarrheal 15.18.6. Antifungal 15.18.7. Anti-histamines 15.18.8. Antihypertensives 15.18.9. Anti-metabolites 15.19. Rest of South America Pediatric Healthcare Market Forecast, By Disease Disorder 15.19.1. Allergy and Respiratory 15.19.2. Cancer 15.19.3. Cardiovascular 15.19.4. Central Nervous System 15.19.5. Gastrointestinal 15.19.6. Hormonal Imbalance 15.19.7. Infections 15.19.8. Others 15.20. Rest of South America Pediatric Healthcare Market Forecast, by Services Type 15.20.1. Child Psychiatry Services 15.20.2. Gastrointestinal Services 15.20.3. Pediatric Cancer Services 15.20.4. Pediatric Diabetes Services 15.20.5. Pediatric Heart Services 15.20.6. Others 15.21. South America Pediatric Healthcare Market Attractiveness Analysis 15.21.1. By Drug Class 15.21.2. By Disease Disorder 15.21.3. By Services Type 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Development 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. AstraZeneca plc 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. Pfizer Inc. 16.3.3. Sanofi S.A. 16.3.4. Boehringer Ingelheim GmbH 16.3.5. Eisai Co., Ltd. 16.3.6. Gilead Sciences, Inc. 16.3.7. GlaxoSmithKline plc. 16.3.8. Merck and Co. Inc. 16.3.9. Mylan N.V. 16.3.10. Novartis AG, 16.3.11. Pediapharm, Inc. 16.3.12. Gilead Sciences, 16.3.13. GlaxosmithklinePlc 16.3.14. Johnson & Johnson 16.3.15. Eli Lilly 16.3.16. AxcanPharmaUSA 17. Primary Key Insights

About This Report

Report ID37290
Category Healthcare
Published Date
No of Pages192
Contact Us